SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJupiter Fund Management Regulatory News (JUP)

Share Price Information for Jupiter Fund Management (JUP)

Share Price is delayed by 15 minutes
Get Live Data
176.00    5.60 (3.29%)
Bid:
176.00
Ask:
176.60
Spread: 0.60 (0.341%)
Market Cap: £883.48m
JUP Live PriceLast checked at - London Stock Exchange

Intraday Jupiter Fund Management Share Chart

Directorate Change

7 May 2021 11:02

RNS Number : 9375X
Jupiter Fund Management PLC
07 May 2021
Β 

Jupiter Fund Management plc (the "Company")

Β 

7 May 2021

Appointment of a Non-Executive Director

Jupiter Fund Management plc is pleased to announce the appointment of David Cruickshank as an independent Non-Executive Director with effect from 1 June 2021.

Β 

David Cruickshank spent his executive career at Deloitte and retired from the firm in June 2020. He qualified as a Chartered Accountant in 1982 and specialised in advising on large international corporate transactions. He was appointed a partner in 1988 and led the UK Tax Practice from 1998 until 2006. He was elected Chair of Deloitte's UK Board in 2007 and served two terms before being elected Chair of Deloitte's Global Board in 2015. During this period David led the Boards through a period of major regulatory change and business transformation and has broad experience across different industry sectors and geographies.

Β 

He has a keen interest in environmental, social and governance ('ESG') matters, having previously chaired the Deloitte Corporate Responsibility Committee in the UK and its Societal Impact Committee globally. He is currently Chair of the Social Progress Imperative Inc and the Education and Employers Charity and previously served as Co-Chair of the Partnering Against Corruption Initiative at the World Economic Forum. He is a member of the Council of the Institute of Chartered Accountants of Scotland.

Β 

Committee Changes

David will join both the Company's Audit and Risk and Nomination Committees with effect from his appointment.

Β 

The Company is separately continuing its search and recruitment for one further Non-Executive Director.

Β 

Nichola Pease, Chairman of the Company commented:

Β 

"We are delighted that David will be joining the Board and look forward to benefiting from his broad experience and detailed understanding of business transformation and ESG matters. His previous experience and financial expertise will also be invaluable to the Group's Audit and Risk Committee and the wider Board."

Β 

David Cruickshank commented:

Β 

"I am very much looking forward to joining the Board of Jupiter and the opportunity to work with a high-quality team, who are focused on driving the growth agenda, and helping them to build on their recent strategic progress."

Β 

The Company confirms that there is no further information to be disclosed under the requirements of Listing Rule 9.6.13R.

Ends

Β 

Jupiter Fund Management plc

LEI Number: 5493003DJ1G01IMQ7S28

Β 

For further information please contact:

Β 

Investors Media

Jupiter Lisa Daniels Despina Constantinides

+44 (0)20 3817 1664 +44 (0)20 3817 1278

Powerscourt Justin Griffiths

+44 (0)20 7250 1446

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOABDLFBFELBBBB
Date   Source Headline
10th Jun 20263:15 pmRNSTransaction in Own Shares - Replacement
9th Jun 202612:15 pmRNSHolding(s) in Company
8th Jun 20264:00 pmRNSTransaction in Own Shares
2nd Jun 20265:19 pmRNSHolding(s) in Company
1st Jun 202611:00 amRNSTransaction in Own Shares
29th May 20265:15 pmRNSTotal Voting Rights
28th May 20263:00 pmRNSDirector/PDMR Shareholding
26th May 20263:45 pmRNSTransaction in Own Shares
18th May 20263:30 pmRNSTransaction in Own Shares
11th May 20264:57 pmRNSTransaction in Own Shares
8th May 20264:00 pmRNSHolding(s) in Company
7th May 20263:30 pmRNSHolding(s) in Company
7th May 20261:00 pmRNSResult of AGM
5th May 20264:00 pmRNSTransaction in Own Shares
5th May 20263:00 pmRNSHolding(s) in Company
5th May 20262:45 pmRNSHolding(s) in Company
30th Apr 20265:00 pmRNSTotal Voting Rights
30th Apr 20262:45 pmRNSHolding(s) in Company
28th Apr 202612:45 pmRNSHolding(s) in Company
27th Apr 20264:02 pmRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTrading Update and Notice of Results
20th Apr 202612:20 pmRNSTransaction in Own Shares
14th Apr 20262:00 pmRNSDirector/PDMR Shareholding
13th Apr 20261:00 pmRNSTransaction in Own Shares
8th Apr 20267:00 amRNSShare Buyback Programme
1st Apr 20263:00 pmRNSDirector/PDMR Shareholding
30th Mar 20263:00 pmRNSDirector/PDMR Shareholding
27th Mar 20263:30 pmRNSDirector/PDMR Shareholding
26th Mar 202612:12 pmRNSHolding(s) in Company
25th Mar 20264:51 pmRNSHolding(s) in Company
24th Mar 20262:03 pmRNSHolding(s) in Company
24th Mar 20262:00 pmRNSAnnual Report and Accounts and Notice of AGM
18th Mar 20262:00 pmRNSHolding(s) in Company
4th Mar 202612:30 pmRNSHolding(s) in Company
4th Mar 202612:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20264:45 pmRNSDirector/PDMR Shareholding
27th Feb 20263:30 pmRNSDirector Shareholding
27th Feb 20263:15 pmRNSTotal Voting Rights
26th Feb 20265:00 pmRNSCancellation of Treasury Shares
26th Feb 20267:00 amRNSAnnual Financial Report
9th Feb 20263:45 pmRNSHolding(s) in Company
6th Feb 20263:26 pmRNSStandard form for notification of major holdings
5th Feb 20262:42 pmRNSHolding(s) in Company
3rd Feb 20262:30 pmRNSHolding(s) in Company
2nd Feb 20261:30 pmRNSHolding(s) in Company
2nd Feb 20269:53 amRNSCompletion of Acquisition of CCLA
22nd Jan 20262:04 pmRNSHolding(s) in Company
7th Jan 20263:15 pmRNSHolding(s) in Company
31st Dec 202511:00 amRNSEntry into Forward Transaction for EBT
31st Dec 202511:00 amRNSEntry into Forward Transaction for EBT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.